In This Section

Evolution of Drug Resistance

Tuesday April 05, 2022

8:00 am - 9:30 am Eastern Time (ET)



DCP

Chair :

James DeGregori
University of Colorado



This session will explore how cancers evolve resistance to therapies. It will explore the importance of tumor heterogeneity, both genetic and epigenetic, and the microenvironment in the evolution of drug resistance. Attendees will also learn about the tradeoffs associated with drug resistance, and how these costs can be exploited for the design of more effective and less toxic therapeutic regimen. The application of evolutionary approaches to understand and to treat cancers will be demonstrated for multiple malignancies, including breast and prostate cancers and multiple myeloma.

Speakers

Robert Gatenby - Moffitt Cancer Center

Exploiting Darwinian Dynamics to Delay or Prevent Evolution of Resistance in Treated Cancer Populations

Talk description coming soon!

Ariosto Silva - Moffit Cancer Center

Evolutionary Dynamics of Disease Progression and Therapy Resistance in Multiple Myeloma

Rena Emond - City of Hope

Talk title coming soon!

Talk description coming soon!

Last Updated: August 31, 2021
Key Dates
 
November 30, 2021

Abstract Submission Deadline

February 7, 2022

Early Registration Deadline

April 2 – 5, 2022

ASPET Annual Meeting at EB 2022

Thank you to our Annual Meeting partners:

jpet_banner
molpharm_banner
dmd_banner
pharmrev_banner